Journal article
FDG positron emission tomographic imaging of thoracic Castleman's disease
Clinical nuclear medicine, Vol.28(4), pp.325-326
2003
DOI: 10.1097/01.RLU.0000057615.73933.2F
PMID: 12642717
Abstract
Fluorodeoxyglucose (FDG) positron emission tomography (PET) has been used to characterize single pulmonary nodules and to stage lung cancer. A cut-off threshold standardized uptake value of 2.5 is reported to provide optimal sensitivity and specificity in distinguishing benign and malignant lesions. The authors describe a patient with a single left hilar lesion on an F-18 FDG-PET scan that was thought to be malignant, but this was proved histopathologically to be Castleman's disease. When PET studies are interpreted, in addition to other benign conditions such as granulomas, infection, and inflammatory processes, clinicians should consider disorders such as Castleman's disease.
Details
- Title: Subtitle
- FDG positron emission tomographic imaging of thoracic Castleman's disease
- Creators
- Madhusudhan P REDDY - Departments of Radiology (Division of Nuclear Medicine), University of Iowa Hospitals and Clinics, Iowa City, Iowa, United StatesMichael M GRAHAM - Rush Presbyterian St. Luke's Medical Center, Chicago, Illinois, United States
- Resource Type
- Journal article
- Publication Details
- Clinical nuclear medicine, Vol.28(4), pp.325-326
- Publisher
- Lippincott; Philadelphia, PA; Hagerstown, MD
- DOI
- 10.1097/01.RLU.0000057615.73933.2F
- PMID
- 12642717
- ISSN
- 0363-9762
- eISSN
- 1536-0229
- Language
- English
- Date published
- 2003
- Academic Unit
- Radiology; Radiation Oncology
- Record Identifier
- 9984046915902771
Metrics
17 Record Views